Hinge Health earnings release, May 5, 2026

Hinge Health, Inc. (HNGE) · Form 8-K, Item 2.02 · Filed · SEC filing

Hinge Health reports record first quarter 2026 financial results

San Francisco, California – May 5, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the first quarter ended March 31, 2026.

“We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “Based on this momentum, we’re raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn’t build this company to stop at digital physical therapy; we built it to transform how healthcare is delivered at scale.”

First Quarter Financial Highlights:

• Revenue increased 47% year-over-year to $182.3 million compared to revenue of $123.8 million in Q1 2025.

• GAAP and Non-GAAP gross margin were 85% compared to 81% in Q1 2025.

• GAAP income from operations increased 144% to $32.1 million compared to GAAP income from operations of $13.1 million in Q1 2025.

Non-GAAP income from operations increased 208% to $46.2 million compared to non-GAAP income from operations of $15.0 million in Q1 2025.

• GAAP diluted net income per share was

$0.41.

Non-GAAP diluted net income per share was

$0.45.

• Net cash provided by operating activities increased to $43.1 million compared to net cash provided by operating activities of $4.9 million in Q1 2025.

Free cash flow increased to $41.6 million compared to free cash flow of $4.2 million in Q1 2025.

• Cash, cash equivalents, marketable securities and restricted cash were $407.1 million as of March 31, 2026.

• Diluted weighted average share count was 82.4 million, a decrease of 2.5% from the diluted weighted average share count of 84.5 million in Q4 2025.

Company Highlights and Key Metrics as of March 31, 2026:

• LTM calculated billings increased 52% year-over-year to $769.9 million, compared to $507.0 million as of March 31, 2025.

• Number of clients increased 23% year-over-year to 2,849 clients, compared to 2,311 clients as of March 31, 2025.

Financial Outlook:

We are providing the following guidance for our second quarter 2026 and full year 2026:

• Q2 2026:

We expect revenue to be between $194 million and $196 million, reflecting year-over-year growth of 40% at the midpoint. We expect non-GAAP income from operations to be between $47 million and $49 million, reflecting year-over-year growth of 84% and non-GAAP operating margin of 25% at the midpoint.

• Full Year 2026:

We expect revenue to be between $798 million and $804 million, reflecting year-over-year growth of 36% at the midpoint. We expect non-GAAP income from operations to be between $205 million and $215 million, reflecting year-over-year growth of 76% and non-GAAP operating margin of 26% at the midpoint.¹

Statement Regarding Use of Non-GAAP Financial Measures

This press release uses non-GAAP financial measures, which are not calculated in accordance with generally accepted accounting principles of the United States (GAAP). For more information about these non-GAAP financial measures, including the limitations of such measures, and for a reconciliation of each measure to the most directly comparable measure calculated in accordance with GAAP, please see the “Non-GAAP Financial Measures” section below.

Moreover, we have not reconciled our non-GAAP income from operations guidance to GAAP income from operations because we do not and are not able to provide guidance for GAAP income from operations due to the uncertainty and potential variability of stock-based compensation expense, employer payroll tax expense related to stock-based compensation, amortization of intangible assets and adjustments, such as acquisition related expense, which are reconciling items between non-GAAP and GAAP income from operations. Because such items cannot be provided without unreasonable efforts, we are unable to provide a reconciliation of the non-GAAP financial measure guidance to the corresponding GAAP measures. However, such items could have a significant impact on our future GAAP income from operations.

Hinge Health Earnings Webcast

We will host a conference call and webcast for investors on May 5, 2026 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss our financial results, business highlights and financial outlook. The live webcast of the conference call can be accessed by registering online at ir.hingehealth.com/events-presentations. Following completion of the event, a webcast replay will also be available at ir.hingehealth.com for 12 months.

About Hinge Health

Hinge Health is focused on scaling and automating the delivery of health care. Leveraging an AI-powered care model, wearable devices and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that helps people move beyond pain that improves member outcomes and experiences while reducing costs for clients. The company is headquartered in San Francisco, California.

Available Information

Our investors and others should note that we announce material information to the public about our company, products and services, and other matters related to our company through a variety of means, including filings with the U.S. Securities and Exchange Commission (“SEC”), the investor relations page on our website (ir.hingehealth.com), press releases, public conference calls, and webcasts in order to achieve broad, non-exclusionary distribution of information to the public and to comply with our obligations under Regulation FD.

Financial statements

Income Statement

Three Months Ended March 31, — (in thousands, except per share data)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Revenue182,307123,825
Cost of revenue28,07423,592
Gross profit154,233100,233
Operating expenses:Research and development30,33823,499
Operating expenses:Sales and marketing68,80246,716
Operating expenses:General and administrative23,02416,881
Operating expenses:Total operating expenses122,16487,096
Operating expenses:Income from operations32,06913,137
Other income:Other income, net3,8735,000
Other income:Net income before income taxes35,94218,137
Other income:Provision for income taxes814998
Other income:Net income35,12817,139
Other income:Adjustment to reflect deemed contribution from Series D and Series E redeemable convertible preferred stock extinguishment104,174
Other income:Undistributed earnings attributable to participating securities-1,117
Other income:Net income attributable to common stockholders, basic34,011121,313
Other income:Net income attributable to common stockholders, diluted34,061121,313
Net income attributable to common stockholders per share:Basic0.437.91
Net income attributable to common stockholders per share:Diluted0.411.31
Weighted average shares used in computing net income per share attributable to common stockholders:Basic78,61915,332
Weighted average shares used in computing net income per share attributable to common stockholders:Diluted82,39492,746

Income Statement

Three Months Ended March 31, — Reconciliation of GAAP to Non-GAAP Financial Measures:

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
GAAP gross profit154,233100,233
GAAP gross margin8581
Non-GAAP adjustments:Stock-based compensation expense (1)837
Non-GAAP adjustments:Employer payroll tax expense related to stock-based compensation105
Non-GAAP adjustments:Amortization of intangible assets225181
Non-GAAP adjustments:Non-GAAP gross profit155,400100,414
Non-GAAP adjustments:Non-GAAP gross margin8581

Income Statement

Three Months Ended March 31, — Reconciliation of GAAP to Non-GAAP Financial Measures:

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
GAAP income from operations32,06913,137
GAAP operating margin1811
Non-GAAP adjustments:Stock-based compensation expense (1)11,6927
Non-GAAP adjustments:Employer payroll tax expense related to stock-based compensation1,484
Non-GAAP adjustments:Amortization of intangible assets225181
Non-GAAP adjustments:Acquisition-related expenses6941,631
Non-GAAP adjustments:Non-GAAP income from operations46,16414,956
Non-GAAP adjustments:Non-GAAP operating margin2512

Balance Sheet

December 31, — (in thousands, except par value data)

March 31, – 2026December 31, – 2025
Current assets:Cash and cash equivalents186,671207,995
Current assets:Short-term marketable securities129,196155,867
Current assets:Accounts receivable, net of allowance for credit losses of $5,957 and $6,092 as of March 31, 2026 and December 31, 2025, respectively114,92166,061
Current assets:Deferred commissions34,50731,344
Current assets:Inventory14,16715,636
Current assets:Prepaid expenses and other current assets60,59257,001
Current assets:Total current assets540,054533,904
Current assets:Long-term marketable securities89,769113,172
Current assets:Goodwill64,09664,096
Current assets:Intangible assets, net2,2872,512
Current assets:Property, equipment and software, net11,35010,490
Current assets:Operating lease right-of-use assets5,9566,861
Current assets:Other assets15,25913,726
Current assets:Total assets728,771744,761
Current liabilities:Accounts payable and accrued liabilities69,47657,331
Current liabilities:Operating lease liabilities4,2344,223
Current liabilities:Deferred revenue340,766300,855
Current liabilities:Total current liabilities414,476362,409
Current liabilities:Operating lease liabilities, noncurrent2,7353,816
Current liabilities:Total liabilities417,211366,225
Redeemable convertible preferred stock:Redeemable convertible preferred stock; $0.00001 par value199,874199,874
Stockholders’ equity:Additional paid-in capital1,127,9021,229,678
Stockholders’ equity:Accumulated other comprehensive loss-348-20
Stockholders’ equity:Accumulated deficit-1,015,868-1,050,996
Stockholders’ equity:Total stockholders’ equity111,686178,662
Stockholders’ equity:Total liabilities, redeemable convertible preferred stock and stockholders’ equity728,771744,761

Cash Flow

Three Months Ended March 31, — (in thousands)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Operating activities:Net income35,12817,139
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Depreciation and amortization1,1731,303
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Stock-based compensation11,6927
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Amortization of deferred commissions16,2059,190
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Accretion of discounts and amortization of premiums on marketable securities, net13549
Adjustments to reconcile net income to net cash provided by (used in) operating activities:Non-cash operating lease expense905845

Cash Flow

Three Months Ended March 31, — (in thousands, except for percentages)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net cash provided by operating activities43,0834,925
Operating cash flow margin24.0%4
Less purchases of property, equipment and software (including capitalized internal use software)-1,530-757
Free cash flow41,5534,168
Free cash flow margin23.0%3
Net cash (used in) provided by investing activities48,081-21,331
Net cash (used in) provided by financing activities-112,8484,104
Full release

Forward-Looking Statements... (truncated) of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this press release may be forward-looking statements. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” or “will,” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements in this release include, but are not limited to, statements regarding our expectations regarding our financial position and operating performance, including our outlook and guidance for the second quarter of 2026 and guidance for full year 2026 and our assumptions underlying such guidance; our ability to drive future growth and execute on our goals and strategies; and our expectations regarding our product innovation. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including those more fully described in our filings with the SEC, including in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 3, 2026 and in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, when filed with the SEC. The forward-looking statements in this press release are based on information available to us as of the date hereof, and we disclaim any obligations to update any forward-looking statements, except as required by law.²

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Hinge Health earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.